
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded oral liquid containing sertraline hydrochloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing sertraline are listed in tablet, capsule and solution forms.
Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Sertraline is a selective serotonin reuptake inhibitor (SSRI) antidepressant that compounding pharmacies prepare as oral capsules and oral liquids by prescription.
Sertraline is a selective serotonin reuptake inhibitor (SSRI). It blocks the reuptake of serotonin by nerve cells in the brain, increasing serotonin activity, with minimal effect on norepinephrine and dopamine uptake. Zoloft tablets and Zoloft oral solution (Viatris) are FDA-approved to treat major depressive disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, social anxiety disorder and premenstrual dysphoric disorder; in children, only OCD has established safety and efficacy. The manufactured oral concentrate contains alcohol, must be diluted in a listed drink before use, and its dropper contains natural rubber latex. A prescriber may order sertraline compounded as an alcohol-free or latex-free oral liquid, or in a strength or capsule not manufactured. Compounded preparations are not FDA-approved and require a prescription.
Sertraline carries an FDA boxed warning: antidepressants increased the risk of suicidal thoughts and behaviors in children and young adults, so watch closely for worsening mood or suicidal thoughts, especially early in treatment and after dose changes. Do not take it with or within 14 days of an MAO inhibitor (including linezolid or methylene blue), with pimozide, or if you are allergic to it; the alcohol-containing oral solution must not be used with disulfiram. Serotonin syndrome can occur with other serotonergic drugs or alone. Aspirin, NSAIDs, warfarin and other blood thinners raise bleeding risk. The label also warns about mania, seizures, angle-closure glaucoma, QT prolongation, low sodium and sexual side effects. Third-trimester use may increase the risk of persistent pulmonary hypertension and withdrawal in the newborn. Breast milk levels are low, and LactMed considers sertraline a preferred antidepressant while nursing. For side effects, talk to your prescriber or pharmacist.
Sertraline potentiates central serotonergic activity by inhibiting neuronal reuptake of serotonin, with minimal effect on norepinephrine and dopamine uptake. Per the Zoloft label, the mean terminal elimination half-life is about 26 hours, steady state is reached after about one week of once-daily dosing with roughly two-fold accumulation, and protein binding is 98 percent; N-desmethylsertraline is the main metabolite. Labeled indications (Zoloft tablets and oral solution): MDD, OCD, panic disorder, PTSD, social anxiety disorder and PMDD; pediatric efficacy is established only for OCD. StatPearls lists off-label use in generalized anxiety disorder, binge eating disorder, bulimia nervosa, body dysmorphic disorder and premature ejaculation. StatPearls notes the commercial oral solution contains alcohol, the basis of the disulfiram contraindication. Dosing per prescriber, with caution and dose reduction in hepatic impairment. Monitor for clinical worsening and suicidality, emergent mania, abnormal bleeding with antiplatelets or anticoagulants, sodium and mental status in older adults, and QTc in patients with risk factors; consider a taper in late pregnancy. Sertraline is not a controlled substance.
Shake the bottle if your label says to. Measure each dose with the oral syringe or dosing cup the pharmacy gave you, never a kitchen spoon. Give the liquid slowly into the mouth. Rinse the syringe with water after each use. Call the pharmacy if you are unsure how to measure.
Storage depends on the vehicle. Water-based liquids with a preservative usually carry a USP <795> beyond-use date of up to 35 days; without a preservative they are kept refrigerated for up to 14 days. Oil-based (nonaqueous) oral liquids may carry up to 90 days. Your label states whether to refrigerate and the beyond-use date. Keep out of reach of children and discard after that date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally